Goff Brian

CIK 00015462165 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001546216

Recent Transactions

50 trades

Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2026-03-02−18,000→ 18,000 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2026-03-02+18,000→ 165,733 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2026-03-02$28.96/sh−5,918→ 164,548 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2026-03-02+8,500→ 151,603 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2026-03-02+13,000→ 170,466 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2026-03-02$28.96/sh−8,267→ 157,466 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2026-03-02−13,000→ 26,000 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2026-03-02$28.96/sh−3,870→ 147,733 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2026-03-02−8,500→ 0 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2026-03-01+48,000→ 48,000 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2026-03-01+174,000→ 174,000 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-12-30$27.09/sh−6,230→ 143,103 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Performance share units
2025-12-30−25,528→ 25,528 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Performance share units
2025-12-30−12,750→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-12-30+25,528→ 149,056 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-12-30+12,750→ 149,333 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-12-30$27.09/sh−12,473→ 136,583 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-08-08−22,691→ 0 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-08-08$36.67/sh−11,085→ 123,528 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-08-08+22,691→ 134,613 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Performance share units
2025-06-24−25,527→ 51,056 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-06-24$33.54/sh−12,471→ 105,401 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-06-24$33.54/sh−6,229→ 111,922 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-06-24+25,527→ 117,872 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Performance share units
2025-06-24−12,750→ 12,750 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-06-24+12,750→ 118,151 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2025-06-11+11,450→ 11,450 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-06-11+8,000→ 23,409 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-03-03$35.54/sh−4,153→ 83,139 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-03-03$35.54/sh−8,794→ 92,345 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-03-01−18,000→ 36,000 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-03-01+8,500→ 87,292 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-03-01+18,000→ 101,139 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2025-03-01+142,500→ 142,500 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-03-01−8,500→ 8,500 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-03-01+39,000→ 39,000 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2024-08-08−22,691→ 22,691 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-08-08$42.75/sh−11,091→ 78,792 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-08-08+22,691→ 89,883 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-06-13+15,409→ 15,409 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2024-06-13+22,297→ 22,297 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-06-05$48.84/sh−12,115→ 67,192 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Performance share units
2024-06-05−25,527→ 76,583 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-06-05+25,527→ 79,307 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-03-05$32.57/sh−4,156→ 53,780 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2024-03-01−8,500→ 17,000 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2024-03-01+195,500→ 195,500 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-03-01+8,500→ 57,936 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2024-03-01+54,000→ 54,000 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-01-24$21.64/sh−7,635→ 49,436 total

Companies

Recent Filings

Address

C/O AGIOS PHARMACEUTICALS, INC. 88 SIDNEY STREET

CAMBRIDGE, MA, 02139

View on SEC.gov